rs144370841
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_012431.3(SEMA3E):āc.2048A>Gā(p.Asn683Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000521 in 1,612,380 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_012431.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SEMA3E | NM_012431.3 | c.2048A>G | p.Asn683Ser | missense_variant | 17/17 | ENST00000643230.2 | NP_036563.1 | |
SEMA3E | NM_001178129.2 | c.1868A>G | p.Asn623Ser | missense_variant | 17/17 | NP_001171600.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SEMA3E | ENST00000643230.2 | c.2048A>G | p.Asn683Ser | missense_variant | 17/17 | NM_012431.3 | ENSP00000496491 | P1 | ||
SEMA3E | ENST00000643441.1 | n.2033A>G | non_coding_transcript_exon_variant | 17/17 |
Frequencies
GnomAD3 genomes AF: 0.000283 AC: 43AN: 152118Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000758 AC: 19AN: 250536Hom.: 0 AF XY: 0.0000517 AC XY: 7AN XY: 135366
GnomAD4 exome AF: 0.0000281 AC: 41AN: 1460144Hom.: 0 Cov.: 32 AF XY: 0.0000289 AC XY: 21AN XY: 726080
GnomAD4 genome AF: 0.000282 AC: 43AN: 152236Hom.: 0 Cov.: 32 AF XY: 0.000309 AC XY: 23AN XY: 74432
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 14, 2021 | The c.2048A>G (p.N683S) alteration is located in exon 17 (coding exon 17) of the SEMA3E gene. This alteration results from a A to G substitution at nucleotide position 2048, causing the asparagine (N) at amino acid position 683 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
CHARGE syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 11, 2023 | This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 683 of the SEMA3E protein (p.Asn683Ser). This variant is present in population databases (rs144370841, gnomAD 0.1%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with SEMA3E-related conditions. ClinVar contains an entry for this variant (Variation ID: 459536). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available". The serine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 03, 2020 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
SEMA3E-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 31, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at